With the Build Back Better reconciliation bill currently stalled, several lawmakers are pushing Congress to find an alternative legislative vehicle to delay the amortization of research and experimental (R&E) expenditures under Section 174.
The Tax Cuts and Jobs Act amended Section 174 to require taxpayers to capitalize and amortize all R&E expenditures over five years (15 years for foreign R&E costs) for tax years beginning in 2022 or later.
While there is broad bipartisan congressional support for retroactively postponing R&E amortization, Congress has not yet been successful in attaching this deferral to a legislative package signed into law. Nevertheless, there are numerous potential bills to which Congress could attach deferral.
There are ongoing discussions about potentially including the Section 174 amortization deferral in the upcoming Omnibus budget bill, which Congress hopes to enact by March 11, when the current continuing resolution funding the federal government will expire.
There are also ongoing discussions about including Section 174 deferral in the semiconductor/competitiveness bill that is expected to be reconciled and enacted in the coming months. The Senate-passed version of this bill—colloquially known as the United States Innovation and Competition Act (USICA)—passed by a 68-32 margin in June 2021, while the House passed its bill—known as America COMPETES—via a 219-203 vote on Feb. 2. These bills are expected to be reconciled and ultimately enacted in the coming months.
Finally, a Section 174 fix could also still be included in a slimmed-down version of the Build Back Better reconciliation bill—or a tax-extenders package that lawmakers expect to enact later this year.
With the timing and ultimate outcome for legislation still uncertain, businesses should consider evaluating their approach for identifying and tracking Section 174 R&E expenditures and determine the potential impact of this new capitalization requirement on items such as the upcoming 2022 first quarter financial statement and estimated tax deadlines.
Tax Legislative Affairs Practice Leader
Dustin Stamper is a managing director in Grant Thornton’s Washington National Tax Office and leads the tax legislative affairs practice for the firm.
Washington DC, Washington DC
Tax professional standards statement
This content supports Grant Thornton LLP’s marketing of professional services and is not written tax advice directed at the particular facts and circumstances of any person. If you are interested in the topics presented herein, we encourage you to contact us or an independent tax professional to discuss their potential application to your particular situation. Nothing herein shall be construed as imposing a limitation on any person from disclosing the tax treatment or tax structure of any matter addressed herein. To the extent this content may be considered to contain written tax advice, any written advice contained in, forwarded with or attached to this content is not intended by Grant Thornton LLP to be used, and cannot be used, by any person for the purpose of avoiding penalties that may be imposed under the Internal Revenue Code.
The information contained herein is general in nature and is based on authorities that are subject to change. It is not, and should not be construed as, accounting, legal or tax advice provided by Grant Thornton LLP to the reader. This material may not be applicable to, or suitable for, the reader’s specific circumstances or needs and may require consideration of tax and nontax factors not described herein. Contact Grant Thornton LLP or other tax professionals prior to taking any action based upon this information. Changes in tax laws or other factors could affect, on a prospective or retroactive basis, the information contained herein; Grant Thornton LLP assumes no obligation to inform the reader of any such changes. All references to “Section,” “Sec.,” or “§” refer to the Internal Revenue Code of 1986, as amended.
More tax hot topics
No Results Found. Please search again using different keywords and/or filters.